FDA Inspection 778051 — Brioschi Pharmaceuticals International LLC

Brioschi Pharmaceuticals International LLC — FEI 2210983

The FDA completed an inspection of Brioschi Pharmaceuticals International LLC on Apr 25, 2012 in Fair Lawn, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 25, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fair Lawn, NJ (United States)

Citations

IDCFRDescription
113321 CFR 211.25(a)GMP Training Frequency
119421 CFR 211.42(c)Defined areas of adequate size for operations
188321 CFR 211.165(a)Testing and release for distribution
202721 CFR 211.192Investigations of discrepancies, failures
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
363221 CFR 211.170(b)Annual visual exams of drug products
436921 CFR 211.188(b)(11)Identification of persons involved, each significant step
437721 CFR 211.188(b)(3)Identification of each component or in-process material

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.